Showing 1629 companies
Company Headquarters: Dolní Dobrouc, Czech Republic Founded: 1990 Workforce: ~224 Company Working: Contipro a.s. (Contipro) is engaged in the production of hyaluronic acid for manufacturing nutritional supplements and active ingredients for cosmetics. It conducts research and development for use of hyaluronan acid in tissue engineering, nanotechnology, wound healing, and drug delivery. The company has marketing network spread across more than 61 countries with over 100 researchers. The company’s sales revenue in 2017 was USD 31.05 million.
Company Headquarters: Massachusetts, US Founded: 1997 Workforce: ~ 250 Company Working: LUTRONIC is a manufacturer and supplier of aesthetic medical devices. The company offers skin care products for melisma, soft tissue incision and tattoo eradication, wrinkle reduction, body and facial contouring, and melisma. The business invests a sizeable portion of its earnings on research and development, developing innovative software to investigate the prospective applications of medical lasers in urology, neurosurgery, and other surgical. specialties. The company sells skin care products online across the US and Europe. The business invests in research and development, developing innovative software to look into the prospective applications of medical lasers in the fields of urology, neurosurgery, and ophthalmology. Lutronic offers customer service to all countries. Moreover, Lutronic spends more than 15% of company revenue on R&D and has more than 270 active and pending patents worldwide. Additionally, Lutronic maintains significant production facilities in Korea, as well as locations in the US, Germany, France, China, and Japan.
Company Headquarters: California, US Founded: 1999 Workforce: ~150+ Company Working: Revance Therapeutics, Inc.is a global healthcare company engaged in the development, manufacture, distribution of botulinum, and other aesthetics & skincare products. The company is a market leader in developing neuromodulators for the treatment of aesthetic and therapeutic conditions. Revance has a strong R&D department, which is providing innovative products. It is pursuing product approval for its blockbuster innovation DaxibotulinumtoxinA for Injection (DAXI) for treatment of crow’s feet, cervical dystonia, adult upper limb spasticity and plantar fasciitis. The company is anticipated to capture significant market share in the therapeutic segment in the botulinum toxin market owing to the strong pipeline.
Unlock Verified Contacts
Access verified employee contacts
Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence